Biology News
Dr. David U'Prichard Joins CerSci Therapeutics' Advisory Board - PR Newswire (press release)


PR Newswire (press release)
Previously, Dr. U'Prichard as CSO was instrumental in the launch of Nova Pharmaceuticals following an academic career as tenured Associate Professor of Pharmacology and Neurobiology at Northwestern University Medical School, and his postdoctoral ...

Associate in Biological Chemistry and Molecular Pharmacology - Times Higher Education (THE)


Times Higher Education (THE)
Associate in Biological Chemistry and Molecular Pharmacology. Harvard Medical School. Biological Chemistry and Molecular Pharmacology. Position Description. The Cellular and Molecular Biosciences Research Program Manager (CAMBR-PM) will be a PhD-level ...

Immunology Conferences - Cordis News


Cordis News
Molecular Immunology 2019 is a two-day programme event that offers a much-needed global platform to bring together researchers in all fields of Immunology, including Molecular Biology, Genetics, Clinical & Cellular Immunology, Microbiology, Vaccines ...

Molecular Insight Pharmaceuticals

Cambridge, Massachusetts - United States

Molecular Insight is a clinical-stage biopharmaceutical company and a pioneer in the emerging field of molecular medicine. The Company is focused on the discovery, development, and commercialization of targeted radiotherapeutics and molecular imaging pharmaceuticals for use in oncology that are intended to improve the lives of patients through timely and accurate detection, improved treatment, and effective monitoring of therapeutic response and disease progression. It has product candidates at various stages of development and/or in different phases in the regulatory approval process in the United States and Europe.

Related
AFT Pharmaceuticals - A New Force In Pharmaceuticals
New Zealand

AFT Pharmaceuticals is a privately owned company with operations in both Australia and New Zealand. The company was founded in 1997 by Dr Hartley Atkinson. AFT operates as a full service pharmaceutical company and also undertakes drug development activities including clinical trials. AFT has a growing portfolio of patented and niche pharmaceuticals which are in the process of being licensed for sale outside the Australasian market.

Insight Biotechnology Ltd.
United Kingdom

Supplier of thermostable DNA polymerases and restriction enzymes, antibodies and recombinant proteins from Wembley, England.

Eco Insight
United Kingdom

Eco Insight, in association with a network of specialists, provides a range of consulting services in the fields of ecology and conservation in Africa.

Insight Pharma Reports
United States

Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts,

Disease Insight Research Foundation
United States

DIRF is a non-profit foundation dedicated to conquering common diseases such as cancer or mental illness through genetic research.

Prolexys Pharmaceuticals, Inc.
United States

Mapping protein-protein interactions and identify new targets for drug discovery to treat cancer and cardiovascular disease. Explains technology platforms and aetology targeted, with FAQ, company alliances and management in Salt Lake City, Utah.

MultiTarget Pharmaceuticals
United States

Manufacturer of AquaPlasmid, a system for the isolation of pure plasmid DNA. The procedure is simpler than alkaline lysis, but the DNA prep is purer than those purified by anion exchange columns, in Salt Lake City, Utah, USA.

Alnylam Pharmaceuticals
United States

Develops novel therapeutics based RNAi. Provides overview of recent drug development programs. Includes company profile and technology information.

Calando Pharmaceuticals
United States

Company developing non-viral technologies for the therapeutic use of RNAi.

RXi Pharmaceuticals
United States

Discovery-stage biotechnology company pursuing the development of RNAi therapeutics for the treatment of neurodegenerative disease, diabetes and obesity.